ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2400

Targeted Exon Resequencing For Korean Rheumatoid Arthritis

So-Young Bang1, Kwangwoo Kim2, Young-Ji Na2, Jaemoon Lee3, Youngho Park4, Sun Young Lee5, Adnan Ahmad Ansari5, Chan-Bum Choi6, Yoon-Kyoung Sung2, Tae-Hwan Kim7, Jae-Bum Jun8, Dae-Hyun Yoo8, Junghee Jung9, Hwanseok Rhee10, Jong-Young Lee11, Bok-Ghee Han12, Sung-Min Ahn13, Sungho Won3, Hye-Soon Lee14 and Sang-Cheol Bae8, 1Hanyang University Guri Hospital, Guri, South Korea, 2Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 3Department of Applied Statistics, Chung-Ang University, Seoul, South Korea, 4Chung-Ang University, Seoul, South Korea, 5Gachon University, Incheon, South Korea, 6Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 7Division of Rheumatology, Department of Internal Medicine, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 8Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 9Bioinfomatics Center, Macrogen Inc, Seoul, South Korea, 10Bioinfomatics Center, Macrogen Inc, Seoul, South Korea, 11Center for Genome Science, Korea National Institute of Health, Osong, South Korea, 12Korea National Institute of Health, Osong, South Korea, 13Deapartment of Translational Medicine, Gachon University, Incheon, South Korea, 14Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Genetics and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Human Etiology and Pathogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disorder with heritability estimated at 65% characterized by arthritis and autoantibodies formation against citrullinated peptides (ACPA). Although there have been many efforts to identify underlying genetic causes of RA by common variants from genome-wide association studies (GWAS), most of around 60 loci identified have modest effect sizes and explained fully little of missing heritability. To discover functional and causal rare variants, we targeted genes outside of MHC region by for which there was reasonable evidence for involvement in Korean RA.

Methods: We performed targeted exon resequencing for 402 candidate genes in non-HLA region for 1,997 Korean RA cases-controls with Agilent’s SureSelect kit (target region = 1.36Mb) on the HiSeq2000 platform. The sequencing data was filtered by our quality control criteria. RA association was assessed by a logistic regression for common markers and by a gene-based analysis using both Score-Seq and SKAT-O for rare coding variants.

Results:  A total of 10,590 high-quality single-nucleotide variants (SNVs) was found in 1,217 cases and 717 healthy controls after applying the quality criteria (minimal depth coverage = 20x). The majority of the variants had low or rare frequency (90.6%) and 7,208 SNV was not reported in public databases like the 1000 genome project data. There were no novel loci associated with RA susceptibility in a single-marker level but we identified a significant accumulation of rare nonsynonymous variants in gene A associated with RA (Score-Seq: P = 3.5 ×10−4, SKAT-O: P = 7.0 ×10−3).

Conclusion: The gene A involved in the differentiation and activation Th17 was associated with RA risk by gene-based approaches of rare coding variants.


Disclosure:

S. Y. Bang,
None;

K. Kim,
None;

Y. J. Na,
None;

J. Lee,
None;

Y. Park,
None;

S. Y. Lee,
None;

A. A. Ansari,
None;

C. B. Choi,
None;

Y. K. Sung,
None;

T. H. Kim,
None;

J. B. Jun,
None;

D. H. Yoo,
None;

J. Jung,
None;

H. Rhee,
None;

J. Y. Lee,
None;

B. G. Han,
None;

S. M. Ahn,
None;

S. Won,
None;

H. S. Lee,
None;

S. C. Bae,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/targeted-exon-resequencing-for-korean-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology